OBX Obsidian Therapeutics, Inc.

Fundamentals / CIK 0002130606 / USD

Obsidian Therapeutics, Inc. reported $340.7M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for OBX.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $0 -- -- $0 -- --
Research & Development $27.55M -- -- $25.05M -- --
Total Operating Expenses $52.91M -- -- $29.63M -- --
Operating Income -$52.91M -- -- -$29.63M -- --
Income Before Tax -$50.66M -- -- -$28.47M -- --
Income Tax Expense $0 -- -- $0 -- --
Net Income -$50.66M -$25.86M -$19.63M -$28.47M -$26.90M -$24.99M
Basic EPS -$1.23 -- -- -$14.77 -- --
Diluted EPS -$1.23 -- -- -$14.77 -- --
Basic Shares Outstanding 41.0M -- -- 1.9M -- --
Diluted Shares Outstanding 41.0M -- -- 1.9M -- --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for OBX.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31
Cash & Cash Equivalents $66.51M -- $40.41M
Short-Term Investments $148.4M -- $40.08M
Cash & Short-Term Investments $324.4M -- $80.50M
Total Current Assets $224.5M $0 $81.52M
Property, Plant & Equipment, Net $961K -- $1.91M
Long-Term Investments $109.4M -- $0
Other Non-Current Assets -- $0 --
Total Non-Current Assets $116.2M $0 $7.06M
Total Assets $340.7M $0 $88.58M
Accounts Payable $569K -- $12K
Other Current Liabilities $1.59M -- $1.42M
Total Current Liabilities $18.26M $0 $15.36M
Other Non-Current Liabilities $0 $0 $3.0K
Total Non-Current Liabilities $1.90M $299.7M $1.23M
Total Liabilities $20.16M $299.7M $16.59M
Total Debt (incl. Leases) $4.05M -- $4.28M
Common Stock $6.0K $0 $1.0K
Retained Earnings -$392.1M $0 -$295.9M
Accumulated Other Comp. Income -$1.20M $0 $23K
Total Stockholders' Equity $320.6M -$299.7M -$266.0M
Total Equity $320.6M -$299.7M -$266.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for OBX.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income $50.66M -$25.86M -$19.63M $28.47M -$26.90M -$24.99M
Stock-Based Compensation $2.26M -- -- $2.23M -- --
Change in Working Capital -- $0 -- -- -- --
Operating Cash Flow -- $0 -- -- -- --
Investing Cash Flow -- $0 -- -- -- --
Financing Cash Flow -- $0 -- -- -- --
Net Change in Cash -- $0 -- -- -- --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for OBX.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 12.29x -- -- -- -- --
Quick Ratio 17.76x -- -- -- -- --
Debt to Equity 0.01x -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002130606) · from March 31, 2025 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal